Patents by Inventor Andrew W. Bridge

Andrew W. Bridge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5159114
    Abstract: Benzanilide derivatives of the formula: ##STR1## wherein R.sup.1 is alkyl optionally containing double or triple bonds, and optionally interrupted by one or more hetero atoms; R.sup.2 is hydrogen, methyl, or ethyl;R.sup.3 is halogen, alkyl, --OY, --SY, or dimethylamino; R.sup.4 and R.sup.5 are hydrogen, alkyl optionally containing double or triple bonds, or --(CH.sub.2).sub.m --Z, wherein: Z is --OCH.sub.3, --SCH.sub.3, --N(CH.sub.3).sub.2 or alkanoylamino, and m is 2, 3 or 4;X is oxygen, --OCH.sub.2 --, --S--, --SCH.sub.2 -- or --NR.sup.6 --;R.sup.6 is hydrogen, methyl, ethyl, or acyl; andY is alkyl; are useful as anti-atherosclerotic agents.
    Type: Grant
    Filed: August 5, 1991
    Date of Patent: October 27, 1992
    Assignee: Rhone-Poulenc Sante
    Inventor: Andrew W. Bridge
  • Patent number: 5004747
    Abstract: Therapeutically useful isoquinolinone derivatives of the formula A--X--R.sup.3, wherein A represents a group of the formula: ##STR1## wherein R.sup.1 and R.sup.2 represents cycloalkyl, alkyl, alkenyl or alkynyl optionally substituted by halogen or cycloalkyl, or represents optionally substituted aryl or heteroaryl, R.sup.4 represents hydrogen, halogen, optionally substituted alkyl, alkenyl or alkynyl, optionally substituted aryl or heteroaryl, or a group R.sup.6 O-- wherein R.sup.6 represents alkyl, aryl or arylalkyl, X represents ethylene or vinylene, R.sup.3 represents a group of the formula:--Y.sup.1 --CH.sub.2 --CH(OH)--CH.sub.2 --COOR.sup.5wherein Y.sup.1 represents carbonyl, hydroxymethylene or --C(OR).sub.2 -- wherein R represents alkyl or the two R symbols together represent alkylene and R.sup.5 represents hydrogen or optionally substituted alkyl or R.sup.
    Type: Grant
    Filed: March 15, 1990
    Date of Patent: April 2, 1991
    Assignee: May & Baker Limited
    Inventors: Michael J. Ashton, Andrew W. Bridge, Robert K. Chambers, Donald I. Dron, Garry Fenton, Neil V. Harris, David J. Lythgoe, Ian M. McFarlane, Christopher G. Newton, David Riddell, Christopher Smith, Keith A. J. Stuttle, Malcolm P. Toft
  • Patent number: 4960775
    Abstract: Therapeutically useful pyrrolo[2,1-a]phthalazine derivatives of the formula: ##STR1## wherein R.sup.1 and R.sup.2 represent cycloalkyl, optionally substituted alkyl, alkenyl, alkynyl, aryl or heteroaryl, X represents ethylene or vinylene, R.sup.3 represents a group of the formula:--Y--CH.sub.2 --CH(OH)--CH.sub.2 --COOR.sup.5wherein Y represents carbonyl or hydroxymethylene and R.sup.5 represents hydrogen or optionally substituted alkyl, or R.sup.3 represents a lactone ring and the symbols R.sup.4 represent hydrogen, halogen, optionally substituted alkyl, alkenyl, alkynyl, aryl or heteroaryl, or R.sup.6 O-- wherein R.sup.6 represents alkyl, aryl or arylalkyl and salts thereof, processes for their preparation and compositions containing them are described.
    Type: Grant
    Filed: December 2, 1988
    Date of Patent: October 2, 1990
    Assignee: May & Baker Limited
    Inventors: Michael J. Ashton, Andrew W. Bridge, Donald I. Dron, Garry Fenton, David J. Lythgoe, Christopher G. Newton, David Riddell, Christopher Smith, Keith A. J. Stuttle
  • Patent number: 4493843
    Abstract: Indole and indoline derivatives of the formula: ##STR1## wherein indicates a double bond or a single bond between carbon atoms, R.sup.1 represents hydrogen, alkyl of 1 through 6 carbon atoms, or alkyl of 1 through 6 carbon atoms substituted by one or more than one of the same type of substituents selected from the hydroxy group, alkenyl groups of 2 through 5 carbon atoms, and alkanoyloxy groups of 2 through 7 carbon atoms, and one of the symbols R.sup.2 represents alkyl of 6 through 24 carbon atoms and the other symbol R.sup.2 represents alkyl of 1 through 24 carbon atoms or hydrogen, and R.sup.3 represents alkyl of 1 through 6 carbon atoms or hydrogen, are new compounds possessing useful pharmacological properties. They are of use in the treatment of diabetes mellitus, hyperlipoproteinaemic states, of atherosclerosis, and of associated conditions.
    Type: Grant
    Filed: May 21, 1982
    Date of Patent: January 15, 1985
    Assignee: May & Baker Limited
    Inventors: Michael J. Ashton, Andrew W. Bridge, Robert F. Chapman, Garry Fenton, Anthony H. Loveless, David Riddell